Dr. Philip Rosenthal, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2323 16th St Ste 407, Bakersfield, CA 93301 Phone: 661-741-0924 Fax: 661-741-0930 |
Dr. Benjamin Jon Serxner, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3838 San Dimas St Ste A140, Bakersfield, CA 93301 Phone: 661-632-7126 Fax: 661-324-3606 |
Dr. Imad Abumeri, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2001 F St, Bakersfield, CA 93301 Phone: 661-404-4731 Fax: 661-404-4732 |
Olusegun B Leramo, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 2601 Oswell St, Suite 101, Bakersfield, CA 93306 Phone: 661-872-9999 Fax: 661-872-1915 |
Dr. William Joseph Meyer, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2201 Mt Vernon Ave, Ste 211, Bakersfield, CA 93306 Phone: 661-872-7000 Fax: 661-872-0499 |
James Scott Johnston, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 Brundage Ln, Bakersfield, CA 93304 Phone: 661-323-6086 Fax: 661-324-6301 |
Dr. Timothy Mitchell Wiebe, MD, FAANS Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3545 San Dimas St, Bakersfield, CA 93301 Phone: 661-323-1947 Fax: 661-323-1904 |
Dr. Jan Mathias Eckermann, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Mt. Vernon Ave., Room 2562-b, Bakersfield, CA 93306 Phone: 661-872-3311 Fax: 661-872-3366 |
News Archive
Roswell Park Cancer Institute has received continuation of a prestigious program project grant from the National Cancer Institute for research through the Roswell Park Photodynamic Therapy Center.
Scientists from the Cancer Science Institute of Singapore at the National University of Singapore have discovered that modifications to a protein called RUNX3 may promote cancer progression.
Delineation of the origin of the retrovirus known as XMRV from the genomes of laboratory mice indicates that the virus is unlikely to be responsible for either prostate cancer or chronic fatigue syndrome in humans, as has been widely published.
Salix Pharmaceuticals, Ltd. and Oceana Therapeutics, LLC today announced that they have entered into a definitive agreement whereby Salix will acquire all of the outstanding stock of Oceana Therapeutics, Inc., a privately-held global provider of gastroenterology and urology therapeutics, for $300 million in cash.
An intravenous "blood thinner" widely used in patients with acute coronary syndromes and during coronary artery stent placement appears to be safe in patients with sickle cell disease and may have beneficial anti-inflammatory effects, a small study at the University of North Carolina at Chapel Hill School of Medicine has found.
› Verified 3 days ago